Ireland Antihypertensive Medicine Sales is set to reach $14.98 Million by 2027 from $17.3 Million, is expected to fall by 3% per year. Italy, Spain and Australia respectively were numbers 2, 3 and 4 in this ranking.
Our readers also like:
Forecast: Renin-Angiotensin System Medicine Sales in Ireland
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Ireland
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Ireland
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Ireland
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Ireland
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Ireland
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Ireland
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Renin-Angiotensin System Medicine Sales in Ireland
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Ireland
- Million Euros
- 2024 to 2028
- ReportLinker Research
Forecast: Antihypertensive Medicine Sales in Ireland
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research